accendra health - ACH

ACH

Close Chg Chg %
1.22 -0.13 -10.25%

Pre-Market

1.10

-0.13 (10.25%)

Volume: 810.84K

Last Updated:

Sep 8, 2026, 3:59 PM EDT

Company Overview: accendra health - ACH

ACH Key Data

Open

$1.24

Day Range

1.08 - 1.24

52 Week Range

0.93 - 5.69

Market Cap

$93.05M

Shares Outstanding

76.90M

Public Float

69.63M

Beta

1.52

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$3.92

Yield

0.00%

Dividend

$0.00

EX-DIVIDEND DATE

Dec 14, 2021

SHORT INTEREST

N/A

AVERAGE VOLUME

2.08M

 

ACH Performance

1 Week
 
-9.09%
 
1 Month
 
-60.71%
 
3 Months
 
-66.97%
 
1 Year
 
-79.40%
 
5 Years
 
-96.90%
 

ACH Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 5
Full Ratings ➔

About accendra health - ACH

Accendra Health, Inc. engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. Its brands include Apria and Byram Healthcare. The company was founded by Otho O. Owens and G. Gilmer Minor in 1882 and is headquartered in Henrico County, VA.

ACH At a Glance

Accendra Health, Inc.
10900 Nuckols Road
Henrico County, Virginia 23060
Phone 1-804-277-4304 Revenue 2.76B
Industry Medical Specialties Net Income -1,100,642,000.00
Sector Health Technology Employees 6,500
Fiscal Year-end 12 / 2026
View SEC Filings

ACH Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 0.078
Price to Book Ratio N/A
Price to Cash Flow Ratio N/A
Enterprise Value to EBITDA 5.75
Enterprise Value to Sales 0.759
Total Debt to Enterprise Value 1.032

ACH Efficiency

Revenue/Employee 424,928.00
Income Per Employee -169,329.538
Receivables Turnover 28.799
Total Asset Turnover 0.777

ACH Liquidity

Current Ratio 0.578
Quick Ratio 0.50
Cash Ratio 0.298

ACH Profitability

Gross Margin 43.504
Operating Margin 5.436
Pretax Margin -3.691
Net Margin -39.849
Return on Assets -2.889
Return on Equity -196.996
Return on Total Capital -6.031
Return on Invested Capital -5.047

ACH Capital Structure

Total Debt to Total Equity N/A
Total Debt to Total Capital 127.077
Total Debt to Total Assets 88.241
Long-Term Debt to Equity N/A
Long-Term Debt to Total Capital 109.851
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Accendra Health - ACH

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
9.96B 10.33B 10.70B 2.76B
Sales Growth
+1.74% +3.80% +3.55% -74.19%
Cost of Goods Sold (COGS) incl D&A
8.36B 8.50B 8.75B 1.56B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
228.67M 287.38M 264.77M 214.52M
Depreciation
135.82M 170.24M 182.78M 140.52M
Amortization of Intangibles
92.85M 117.14M 82.00M 74.00M
COGS Growth
-0.06% +1.66% +2.95% -82.16%
Gross Income
1.60B 1.84B 1.95B 1.20B
Gross Income Growth
+12.31% +15.03% +6.34% -38.52%
Gross Profit Margin
+16.05% +17.78% +18.26% +43.50%
2022 2023 2024 2025 5-year trend
SG&A Expense
1.41B 1.63B 1.71B 1.05B
Research & Development
- - - -
-
Other SG&A
1.41B 1.63B 1.71B 1.05B
SGA Growth
+36.91% +15.82% +5.09% -38.37%
Other Operating Expense
- - (17.12M) (2.42M)
-
Unusual Expense
55.02M 95.61M 457.04M 122.70M
EBIT after Unusual Expense
137.66M 114.96M (195.55M) 27.46M
Non Operating Income/Expense
1.47M (2.05M) (10.17M) (214.00K)
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
128.24M 167.63M 151.63M 129.20M
Interest Expense Growth
+166.67% +30.72% -9.55% -14.79%
Gross Interest Expense
128.24M 167.63M 151.63M 129.20M
Interest Capitalized
- - - -
-
Pretax Income
10.89M (54.73M) (357.36M) (101.95M)
Pretax Income Growth
-96.06% -602.49% -552.99% +71.47%
Pretax Margin
+0.11% -0.53% -3.34% -3.69%
Income Tax
(11.50M) (13.43M) 5.33M 729.00K
Income Tax - Current - Domestic
6.21M 5.42M 26.22M 16.98M
Income Tax - Current - Foreign
8.65M 4.89M 5.22M 1.64M
Income Tax - Deferred - Domestic
(14.07M) (22.90M) (25.72M) (17.89M)
Income Tax - Deferred - Foreign
- (12.29M) (829.00K) (393.00K)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
22.39M (41.30M) (362.69M) (102.68M)
Minority Interest Expense
- - - -
-
Net Income
22.39M (41.30M) (362.69M) (102.68M)
Net Income Growth
-89.90% -284.47% -778.15% +71.69%
Net Margin Growth
+0.22% -0.40% -3.39% -3.72%
Extraordinaries & Discontinued Operations
- - - (997.96M)
-
Discontinued Operations
- - - (997.96M)
-
Net Income After Extraordinaries
22.39M (41.30M) (362.69M) (1.10B)
Preferred Dividends
- - - -
-
Net Income Available to Common
22.39M (41.30M) (362.69M) (1.10B)
EPS (Basic)
0.3005 -0.545 -4.7261 -14.3132
EPS (Basic) Growth
-90.14% -281.36% -767.17% -202.85%
Basic Shares Outstanding
74.50M 75.78M 76.74M 76.90M
EPS (Diluted)
0.2938 -0.545 -4.7261 -14.3132
EPS (Diluted) Growth
-89.99% -285.50% -767.17% -202.85%
Diluted Shares Outstanding
76.22M 75.78M 76.74M 76.90M
EBITDA
421.35M 497.94M 526.26M 364.68M
EBITDA Growth
-13.48% +18.18% +5.69% -30.70%
EBITDA Margin
+4.23% +4.82% +4.92% +13.20%

Snapshot

Average Recommendation HOLD Average Target Price 2.313
Number of Ratings 5 Current Quarters Estimate 0.009
FY Report Date 09 / 2026 Current Year's Estimate 0.019
Last Quarter’s Earnings -0.19 Median PE on CY Estimate N/A
Year Ago Earnings 1.01 Next Fiscal Year Estimate 0.182
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 4 5 4 5
Mean Estimate 0.01 0.26 0.02 0.18
High Estimates 0.03 0.37 0.07 0.44
Low Estimate -0.03 0.16 -0.04 -0.18
Coefficient of Variance 289.39 28.92 272.69 137.63

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 0 0 1
OVERWEIGHT 0 0 1
HOLD 4 4 2
UNDERWEIGHT 0 0 0
SELL 1 1 1
MEAN Hold Hold Hold

Accendra Health in the News